Nanjing Historical Income Statement

688580 Stock

27.26 0.11 0.40%

Historical analysis of Nanjing Vishee income statement accounts such as Net Interest Income of 21.7 M, Interest Income of 23.3 M or Interest Expense of 1.6 M can show how well Nanjing Vishee Medical performed in making a profits. Evaluating Nanjing Vishee income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Nanjing Vishee's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Nanjing Vishee Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nanjing Vishee Medical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Nanjing Vishee Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Nanjing Income Statement Analysis

Nanjing Vishee Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Nanjing Vishee shareholders. The income statement also shows Nanjing investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Nanjing Vishee Income Statement Chart

At present, Nanjing Vishee's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 21.7 M, whereas Selling General Administrative is forecasted to decline to about 96.7 M.

Tax Provision Selling General Administrative Total Revenue Gross Profit

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Total Revenue

Total revenue comprises all receipts Nanjing Vishee Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Nanjing Vishee Medical minus its cost of goods sold. It is profit before Nanjing Vishee operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Nanjing Vishee's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Nanjing Vishee Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Nanjing Vishee Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2022	2023	2024	2025 (projected)
Gross Profit	233.1M	331.7M	381.5M	261.0M
Total Revenue	321.6M	462.2M	531.6M	355.7M

Gross Profit Total Revenue

Nanjing Vishee income statement Correlations

	Tax Provision	Net Interest Income	Interest Income	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Net Income	Income Tax Expense	Minority Interest
Tax Provision		0.61	0.62	0.67	0.85	0.87	0.36	0.96	0.93	0.97	0.77	0.97	0.82	0.77	0.67	0.94	0.93	0.99	-0.76
Net Interest Income	0.61		1.0	0.85	0.84	0.84	0.9	0.7	0.8	0.74	0.9	0.73	0.85	0.88	0.95	0.78	0.8	0.56	-0.96
Interest Income	0.62	1.0		0.87	0.85	0.85	0.91	0.71	0.8	0.74	0.91	0.73	0.86	0.89	0.96	0.79	0.8	0.57	-0.96
Selling General Administrative	0.67	0.85	0.87		0.95	0.94	0.82	0.79	0.84	0.75	0.93	0.72	0.97	0.98	0.92	0.83	0.84	0.58	-0.89
Total Revenue	0.85	0.84	0.85	0.95		1.0	0.69	0.94	0.97	0.91	0.97	0.89	1.0	0.99	0.89	0.96	0.97	0.79	-0.92
Gross Profit	0.87	0.84	0.85	0.94	1.0		0.68	0.95	0.97	0.92	0.97	0.9	0.99	0.98	0.88	0.97	0.97	0.81	-0.92
Other Operating Expenses	0.36	0.9	0.91	0.82	0.69	0.68		0.45	0.55	0.48	0.71	0.44	0.73	0.77	0.93	0.53	0.55	0.3	-0.82
Operating Income	0.96	0.7	0.71	0.79	0.94	0.95	0.45		0.98	0.96	0.88	0.96	0.91	0.87	0.74	0.99	0.98	0.93	-0.82
Net Income From Continuing Ops	0.93	0.8	0.8	0.84	0.97	0.97	0.55	0.98		0.97	0.94	0.97	0.94	0.92	0.8	1.0	1.0	0.89	-0.89
Ebit	0.97	0.74	0.74	0.75	0.91	0.92	0.48	0.96	0.97		0.87	1.0	0.88	0.85	0.76	0.98	0.97	0.96	-0.87
Research Development	0.77	0.9	0.91	0.93	0.97	0.97	0.71	0.88	0.94	0.87		0.87	0.96	0.97	0.88	0.93	0.94	0.7	-0.95
Ebitda	0.97	0.73	0.73	0.72	0.89	0.9	0.44	0.96	0.97	1.0	0.87		0.86	0.83	0.73	0.97	0.97	0.96	-0.85
Cost Of Revenue	0.82	0.85	0.86	0.97	1.0	0.99	0.73	0.91	0.94	0.88	0.96	0.86		1.0	0.9	0.94	0.94	0.75	-0.92
Total Operating Expenses	0.77	0.88	0.89	0.98	0.99	0.98	0.77	0.87	0.92	0.85	0.97	0.83	1.0		0.92	0.91	0.92	0.7	-0.93
Reconciled Depreciation	0.67	0.95	0.96	0.92	0.89	0.88	0.93	0.74	0.8	0.76	0.88	0.73	0.9	0.92		0.8	0.8	0.61	-0.95
Income Before Tax	0.94	0.78	0.79	0.83	0.96	0.97	0.53	0.99	1.0	0.98	0.93	0.97	0.94	0.91	0.8		1.0	0.91	-0.89
Net Income	0.93	0.8	0.8	0.84	0.97	0.97	0.55	0.98	1.0	0.97	0.94	0.97	0.94	0.92	0.8	1.0		0.89	-0.89
Income Tax Expense	0.99	0.56	0.57	0.58	0.79	0.81	0.3	0.93	0.89	0.96	0.7	0.96	0.75	0.7	0.61	0.91	0.89		-0.71
Minority Interest	-0.76	-0.96	-0.96	-0.89	-0.92	-0.92	-0.82	-0.82	-0.89	-0.87	-0.95	-0.85	-0.92	-0.93	-0.95	-0.89	-0.89	-0.71

Click cells to compare fundamentals

Nanjing Vishee Account Relationship Matchups

Nanjing Vishee income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Tax Provision	22.9M	19.8M	12.0M	13.8M	15.8M	16.0M
Net Interest Income	6.0M	16.6M	18.9M	18.0M	20.7M	21.7M
Interest Income	6.4M	16.8M	19.3M	19.3M	22.2M	23.3M
Interest Expense	412.8K	184.7K	334.0K	1.3M	1.5M	1.6M
Selling General Administrative	85.1M	92.2M	101.2M	141.0M	162.2M	96.7M
Total Revenue	378.4M	430.0M	321.6M	462.2M	531.6M	355.7M
Gross Profit	278.6M	321.6M	233.1M	331.7M	381.5M	261.0M
Other Operating Expenses	3.5M	4.1M	16.4M	217.2M	249.7M	262.2M
Operating Income	146.2M	158.4M	70.2M	123.0M	141.5M	113.7M
Net Income From Continuing Ops	143.1M	177.5M	93.8M	136.3M	156.7M	118.3M
Ebit	109.4M	141.8M	158.4M	104.5M	120.1M	114.1M
Research Development	34.3M	63.5M	43.7M	57.7M	66.3M	40.6M
Ebitda	123.6M	175.3M	208.6M	123.3M	141.8M	138.4M
Cost Of Revenue	99.8M	108.5M	88.5M	130.5M	150.1M	94.7M
Total Operating Expenses	232.2M	271.6M	251.4M	339.2M	390.1M	242.0M
Reconciled Depreciation	8.8M	11.1M	17.1M	20.1M	23.2M	24.3M
Income Before Tax	166.1M	197.4M	105.8M	150.0M	172.5M	134.2M
Net Income Applicable To Common Shares	99.7M	143.7M	177.8M	93.9M	108.0M	113.4M
Net Income	143.7M	177.8M	93.8M	136.3M	156.7M	118.6M
Income Tax Expense	15.9M	22.9M	19.8M	12.0M	13.7M	16.1M
Minority Interest	8.7M	5.6M	5.0M	275.3K	247.8K	235.4K

Currently Active Assets on Macroaxis

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin
ADA	Cardano
XRP	XRP

Other Information on Investing in Nanjing Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nanjing Historical Income Statement

About Nanjing Income Statement Analysis

Nanjing Vishee Income Statement Chart

Tax Provision

Total Revenue

Gross Profit

Nanjing Vishee income statement Correlations

Nanjing Vishee Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nanjing Vishee income statement Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Nanjing Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Interest Income	+ 1.0	Net Interest Income
Gross Profit	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Income Before Tax	+ 1.0	Net Income From Continuing Ops
Net Income	+ 1.0	Net Income From Continuing Ops
Ebitda	+ 1.0	Ebit

Minority Interest	- 0.96	Interest Income
Minority Interest	- 0.96	Net Interest Income
Minority Interest	- 0.95	Reconciled Depreciation
Minority Interest	- 0.95	Research Development
Minority Interest	- 0.93	Total Operating Expenses
Minority Interest	- 0.92	Cost Of Revenue